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1. Introduction
  Prostate cancer (Pca) is a malignant tumor of urinary 
system with remarkably biological genetic characteristics 
and the rate of its occurrence is high in Europe and 
the United State[1] but it is low in Asia. So far, its exact 
pathogenesis and the reason of different prevalence among 
different races are not clear. Studies in recent years showed 
that the gene polymorphism of androgen receptor (AR), 
especially the polymorphism of repetitive sequence in CAG 
(the first exon), is closely related to the occurrence and 
development of prostate cancer[2-5]. But most of the studies 
focused on the population in Europe and the United State 
where the risk of prostate cancer is high. Study reports about 
the polymorphism of related susceptibility gene of prostate 
cancer in Han population in our country are few. To make a 
further study about the relation between the polymorphism 
of repetitive sequence in CAG of androgen receptor in Han 
population and the biological characteristics of prostate 
cancer, we made a comparison about the polymorphism of 
repetitive sequence in CAG among the patients at the same 
clinical stage and with different pathological grading and 
healthy people.   
Objective: To explore the relation between the polymorphism of repetitive sequence in gene 
CAG of androgen receptor (AR) and the susceptibility and clinical stages as well as pathological 
grading of prostate cancer among Han population. Method: Sixty-eight cases with prostate 
cancer hospitalized in Urinary Surgery Department from Feb. 2010 to Feb. 2012 and 60 healthy 
cases were chosen as research subjects. Methods of PCR and direct sequencing were adopted 
to detect DNA sequence of AR gene and the length of repetitive sequence in CAG. Results: The 
lengths of repetitive sequence in CAG of patients with prostate cancer and healthy people were 
(22.3依4.6) and (23.0依4.9), respectively showing no statistical significance. Comparing length 
(repetitive sequence of CAG)>22, those with that ﹤ 22 suffer a remarkably higher risk of prostate 
cancer (P﹤0.05). The number of repetitive sequence in CAG of patients at clinical stage C-D was 
less than that of patients at stage B, and the number of repetitive sequence in CAG of patients 
with poorly differentiated prostate cancer was also less than that of patients with moderately 
and highly differentiated prostate cancer. But there was no statistical significance int the 
difference (P>0.05); the proportion of patients with length ﹤22 at clinical stage C-D was much 
larger than that of patients at clinical stage B (P﹤0.05), and as the aggravation of pathological 
grading, the proportion of patients with the length ﹤22 was also remarkably increased and there 
was significant difference between patients with highly differentiated prostate cancer and those 
with poorly differentiated prostate cancer (P﹤0.05). Conclusions: There is correlation between 
the occurrence and development of prostate cancer in Han population and the polymorphism 
of repetitive sequence in gene CAG of androgen receptor. The less the number of repetitive 
sequence in CAG is, the higher the risk of prostate cancer will be and the more severe the clinical 
stage and pathological grading will be.
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2. Materials and methods
2.1. General materials
  Sixty-eight patients who came to urinary surgery 
department of our hospital during the period from Feb. 
2010 to Feb. 2012 were enrolled. They were all diagnosed 
as prostate cancer by biopsy or operation and pathological 
examination. The range of their ages was 54-86 years and 
the average age was (67.4依7.8) years according to Whitmore-
Jewett, there are 42 cases at stage B, 18 cases at stage C 
and 8 cases at stage D; according to Gleason evaluation 
standards, there are 48 cases with highly differentiated 
Pca (2-4 scores), 11 cases with moderately differentiated 
Pca (5-7 scores) and 9 cases with poorly differentiated Pca 
(8-10 scores). Sixty healthy cases (without the history of 
hyperplasia of prostate gland and prostate cancer) who came to 
the examination center in our hospital during the same period 
were chosen as control group. The range of their ages was 53-
87 and the average age was (67.9依8.9) years. All the subjects 
were Han population and agreed to participate in the study.
2.2. Methods 
2.2.1. Extraction of DNA in peripheral blood
  Peripheral venous blood 4 mL was collected from each 
subject with a empty stomach. 0.2% EDTA-Na2 was used for 
anti-freezing. Improved salting out method[6] was used to 
extract DNA (Rapid extraction of genomic DNA Kit, Beijing 
SaiBaiSheng Gene Technology Co., Ltd.) and DNA was stored 
in fridge at -70  曟.
2.2.2. PCR amplification of repetitive sequence in CAG
  Two pairs of primers were synthesized according to 
Irvine RA methods[7,8] and two rounds of PCR reaction 
were performed on them. The upstream primer F1 was 5’-
GTGCGCGAAGTGATCCAGAA-3’ and R1 was 5’-TCTG- 
GGACGCAACCTCTCTC-3’; the downstream primer F2 was 
5’-AGAGGCCGCGAGCGCAGCAC-CTC-3’ and R2 was 
5’-GCTGTGAAGGTTGCTGTTCCTCAT-3’. PCR reaction 
system 50 毺L contains genomic DNA 100ng. Amplification 
parameters: the reaction conditions of the first round were 
60s denaturation at 94 曟, 60s annealing at 55 曟 and stretch 
90s at 72 曟 and there were 17 circulations in total; the 
reaction conditions of the first round were 60s denaturation 
at 94 曟, 60s annealing at 66 曟 and stretch 90s at 72 曟 and 
there were 28 circulations in total.  
2.2.3. Analysis of amplified products
  PCR products  were  placed on agarose  gel  for 
electrophoresis. The existence of objective gene fragment 
(200-250 bp) was confirmed. The products were purified 
(OMEGA Bio-tek Company Kit). The DNA sequence of 
products and the length of repetitive sequence in CAG were 
measured by ABI377DNA sequencer (Shanghai Boya Ltd.).
2.3. Statistic analysis 
  Software SPSS15.0 was used for statistical processing, 
measurement data were symbolized by x依s, t test, x
2 test 
as well as single factor analysis of variance were used. 
Difference were considered as significant at P<0.05. 
3. Results
3.1. Relation between polymorphism of repetitive sequence in 
CAG of AR and the susceptibility of Pca
  The length of repetitive sequence in CAG of 68 patients 
with Pca was 16-31 and the average length was (22.3依4.6); 
length of that of healthy cases was 18-31 and the average 
length was (23.0依4.9). There was no significant difference in 
the average length of repetitive sequence between CAG of 
patients and that of healthy people (t=0.83, P>0.05). Using 
22 as the critical value[9], we divided them into short CAG 
group (the repetitive sequence of CAG ﹤22) and long CAG 
group (the repetitive sequence≥22 ). There was significant 
difference between the two groups (x2=3.97, P﹤0.05) (Table 1).
3.2. Relation between the polymorphism of repetitive sequence 
in CAG of AR and the clinical stage of Pca
  The average length of repetitive sequence in CAG of 
patients with prostate cancer at stage B was (22.8依3.1) and 
the average length of repetitive sequence in CAG of patients 
with prostate cancer at stage C-D was (21.5依3.5). There was 
no statistical significance in the difference (t=1.58, P>0.05). 
There were 15 cases (35.7%) in short CAG group at stage B 
and 27 cases (64.3%) in long CAG group; there are 17 cases 
(65.4%) in short CAG group at stage C-D and 9 cases (34.6%) 
in long CAG group. There was remarkable difference in the 
comparison between patients at stage B and those at stage 
C-D (x2=4.55, P﹤0.05) (Table 2).
3.3. Relation between the polymorphism of repetitive sequence 
in CAG of AR and the pathological grading of Pca
  The lengths of repetitive sequence in CAG of patients with 
pooly, moderately and highly differentiated prostate cancer 
were (20.3依3.6), (21.3依3.8) and (22.9依4.3), respectively. The 
length of repetitive sequence in CAG of patients with poorly 
differentiated prostate cancer was shorter than that of those 
with moderately and highly differentiated prostate cancer 
Table 1
Comparison between the polymorphism of repetitive sequence in CAG of AR of patients with Pca and healthy people.
Group n Length of repetitive sequence in CAG
Distribution of repetitive sequence in CAG
＜22 ≥22
Pca group 68 22.3依4.6   32(47.1%)*  36(52.9%)*
Healthy group 60 23.0依4.9 17(28.3%) 43(71.7%)
Comparison between Pca group and healthy group:*P﹤0.05.
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while there was no statistical significance in the difference 
(t=1.14, 1.70, P>0.05). The distribution of repetitive 
sequence in CAG of AR in short CAG group expanded as 
the pathological grading of prostate cancer aggravated. 
There was significant difference in the comparison between 
patients with highly differentiated Pca and those with poorly 
differentiated Pca (x2=6.13, P﹤0.05) (Table 3).  
4. Discussion
  Prostate cancer is one of the malignant tumors in males. 
Its pathogenesis is closely related to androgen and the 
function of androgen is adjusted by androgen receptor (AR). 
AR is the member of the superfamily of steroid receptor 
and it mainly plays its role in N gene. The most remarkable 
characteristic of AR is that it contains one CAG with triad 
nucleotide repetitive sequences. The number of triad 
nucleotide repetitive sequences in CAG is 9-36 in healthy 
people[10-11]. The American Blacks have smallest number 
of that, the Whites rank the second and Asian Americans 
have the largest number of that, which just conforms to 
epidemiological investigation which showed the risk of 
prostate cancer in different races[12-14]. This may show that 
the polymorphism of repetitive sequence in CAG of AR is 
relevant with the occurrence and development of prostate 
cancer. 
  Currently, disputes about the relation between the 
polymorphism of repetitive sequence in CAG of AR and 
prostate cancer exist in both domestic and foreign studies. 
Some scholars argued that the less the number of repetitive 
sequence in CAG was, the higher the risk of prostate cancer 
would be[15-17]. Studies conducted by Akinloye and his 
colleagues[18] showed that every time the CAG fragment 
was increased by one, the risk of prostate cancer would be 
decreased by 3%. But other scholars believed that the length 
of repetitive sequence in CAG was not the risk factor of 
prostate cancer[19,20] and was not significantly related to the 
clinical stages and pathological grading of prostate cancer[21-
23]. The studies on the population of Brazil conducted by 
Silva Neto B and his colleagues[24,25] showed that compared 
with that of normal people, the length of repetitive sequence 
in CAG of patients with prostate cancer was not remarkably 
shortened.  
  In our study, we firstly made a comparison about the 
polymorphism of repetitive sequence in CAG of AR between 
the 68 cases with prostate cancer and 60 healthy cases and 
found there was no significant difference in the average 
length of repetitive sequence in CAG in the two groups. To 
further understand the relation between the polymorphism of 
repetitive sequence in CAG and the susceptibility of prostate 
cancer, we, according to the reference and regarding 22 
as standard[9], divided them into short CAG group (the 
repetitive sequence of CAG ﹤22) and long CAG group (the 
repetitive sequence≥22 ). The results showed that the risk 
of prostate cancer in short CAG group increased remarkably 
(P﹤0.05), which conforms to most of foreign reports[26-30]. 
Then we studied the relation between the polymorphism of 
repetitive sequence in CAG of AR and the clinical stages and 
pathological grading of prostate cancer. The results showed 
that the number of repetitive sequence in CAG of patients 
at clinical stage C-D is less than that of patients at stage B, 
and the number of repetitive sequence in CAG of patients 
with poorly differentiated prostate cancer is also less than 
that of patients with moderately and highly differentiated 
prostate cancer. But there is no statistical significance in 
the difference, which may be caused by the small amount 
of samples. Still regarding 22 as the critical value, through 
comparison, it was found that the proportion of patients at 
clinical stage C-D in short CAG group is remarkably larger 
than those at stage B. As the aggravation of pathological 
grading, the proportion of patients with the length ﹤22 is 
remarkably increased and there is significant difference 
between patients with highly differentiated prostate cancer 
and those with poorly differentiated prostate cancer. 
  To sum up, our study holds the opinion that there is 
relation between the occurrence and development of 
prostate cancer in Han population and the polymorphism of 
repetitive sequence in CAG of AR. The less the number of 
repetitive sequence in CAG is, the higher the risk of prostate 
cancer will be and the more advance the clinical stage and 
pathological grading will be. However, since the samples 
are relatively small, there is no statistical difference in the 
average length of repetitive sequence in CAG among groups, 
which needs to be further studied with more samples.
Table 2
Relation between the polymorphism of repetitive sequence in CAG of AR and the clinical stage of Pca.
Staging of tumor n Length of repetitive sequence in CAG
Distribution of repetitive sequence in CAG
＜22 ≥22
Stage B 42 22.8依3.1 15(35.7%) 27(64.3%)
Stage C-D 26 21.5依3.5 17(65.4%)*   9(34.6%)*
Comparison between patients at stage C-D and those at stage B:*P﹤0.05.
Table 3 
Relation between the polymorphism of repetitive sequence in CAG of AR and the pathological grading of Pca.
Pathological grading n Length of repetitive sequence in CAG
Distribution of repetitive sequence in CAG
＜22 ≥22
Poor differentiation   9 20.3依3.6   8(88.9%)  1(11.1%)
Moderate differentiation 11 21.3依3.8   6(54.5%)  5(45.5%)
High differentiation 48 22.9依4.3 18(37.5%) 30(62.5%)*
Compared with those poor differentiation:*P﹤0.05.
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